Early Prostate Cancer Trial Has Promising Signs The purpose of this Phase I trial was to see if encapsulated rapamycin (eRapa) is safe for men with early signs of cancer. That involved closely monitoring patients at low or medium level risk. Dr. Phillip Kemp Bohan at Brooke Army Medical Center led the study. The primary…